Viking Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. DPZ
6. PRIM
7. META
8. N2EW34
9. INTC
10. IMNN

Go back to Viking Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update

Viking Therapeutics (VKTX) Tops Q4 EPS by 4c

March 7, 2018 4:09 PM EST

Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($0.14), $0.04 better than the analyst estimate of ($0.18).

At December 31, 2017, Viking held cash, cash equivalents and investments totaling $20.6 million. In February 2018, Viking sold an aggregate of 12,650,000 shares of its common stock resulting in gross proceeds of $63.3 million before... More